Alembic Pharmaceuticals Limited has informed the Exchange regarding 'USFDA inspection at Alembic Pharmaceuticals Limited s API - I & II Facility located at Panelav'.
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals has informed the stock exchange about a USFDA inspection at its API (Active Pharmaceutical Ingredient) I and II manufacturing facility in Panelav, Gujarat. The announcement only states that the inspection took place, with no mention of the outcome, any observations, or regulatory action. USFDA inspections are routine regulatory checks for pharma companies exporting to the United States. The market will watch for any follow-up filing disclosing the inspection result, such as a Form 483 or Establishment Inspection Report.
Neutral in the short term, as the outcome of the inspection is not disclosed. If the inspection results in observations or a warning letter, it could negatively affect the stock and future US sales from this facility.